Related Experiment Video
Updated: Aug 9, 2026
05:46
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
Key questions in antiretroviral therapy: Italian Consensus Workshop (2005)
G Carosi1, C Torti, M Andreoni
1Department of Infective and Tropical Diseases, University of Brescia, Piazzale Spedali Civili I, I-25123 Brescia, Italy.
The Journal of Antimicrobial Chemotherapy
|April 12, 2006
Summary
Italian experts established consensus recommendations for antiretroviral therapy (ART) in 2005, addressing critical questions on initiating, switching, and managing HIV treatment for optimal patient outcomes.
Area of Science:
- Infectious Diseases
- Virology
- Immunology
Background:
- A 2005 meeting convened leading Italian specialists to address key challenges in antiretroviral therapy.
- The panel focused on critical decision points in managing HIV treatment.
Framework:
- A nominal group meeting methodology was employed.
- Recommendations were graded for strength and quality, referencing the Infectious Diseases Society of America's system.
Implementation:
- The consensus statement addresses when to start, how to start, when to switch, what to switch to, and whether/how to stop antiretroviral therapy.
- Recent supporting data for these recommendations are included.
Implications:
- Provides evidence-based guidance for clinicians managing patients on antiretroviral therapy.
- Aims to optimize treatment strategies and improve patient outcomes in HIV care.
More Related Videos
Related Concept Videos
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
01:19Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
01:28Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...